Skip to content
Business
Primers

Labcorp to Offer Monkeypox Testing as Part of US Diagnosis Effort

An electron microscopic image depicting a monkeypox virion.

An electron microscopic image depicting a monkeypox virion.

Source: CDC

Labcorp will offer testing for monkeypox, part of the Biden administration’s effort to make diagnosis more widely available as the virus spreads across the US and the world. 

The company will begin testing for the disease Wednesday. Its test detects the presence of genetic material from the virus and was developed by the US Centers for Disease Control and Prevention, North Carolina-based Labcorp said in a statement. The company aims to raise its capacity to 10,000 tests a week, doubling the current level now available through CDC.